CASE STUDY: Unbranded Signature
Resource in Line With Personalized
Medicine Oncology Portfolio
Increase payer and provider knowledge and coverage of oncology biomarker testing.
Develop an industry-leading trends report for account managers to use with hospital decision makers and payers to raise awareness of gaps between oncologist utilization and payer coverage, factors influencing coverage and utilization.
7th edition is currently in development.
Coverage of the biomarker for the company’s most recent oncology launch increased threefold versus 2018.
We are thrilled with the quality of the Annual Trend Report and the positive reception and appreciation it garners with customers every year. The report continues to support our leadership position in precision oncology. We value Aventria as our precision oncology agency partner as they commence development of the 7th edition.”
Director, Strategic Market Access